Abstract
Lung cancer is a neoplasm with a 5-year survival rate of less than 15 % and a leading cause of death worldwide, despite recent progress in treatment and diagnostic methods. Lung cancer stem-like cells (CSCs) are pivotal in lung cancer metastasis and drug resistance. This study aimed to develop lung CSCs that stably express stem cell properties through transfection to further screen traditional Chinese herbal compounds. Lung adenocarcinoma stem cells, which include various phenotypic subgroups, are normally characterized by high expression levels of pluripotent stem cell genes, particularly Nanog and OCT4. Plasmids containing Nanog and OCT4 were constructed and transfected into cells, and lung CSCs were identified not only in vitro using RT-PCR, Western blotting, plate cloning, sphere formation, drug resistance, and transwell migration but also in vivo using a nude mouse tumorigenicity assay. Subsequently, sanguinarine, which is derived from the whole leaves of the traditional Chinese medicine celandine, was identified through the high-throughput screening of a small-molecule compound library. Investigation of the molecular mechanisms of the effects of sanguinarine revealed that it significantly inhibited lung CSC proliferation, invasion, and apoptosis, possibly via downregulation of the Wnt/β-catenin signaling pathway. Our results indicate that lung CSCs established by gene transfection may provide a stable and effective method of constructing CSCs to effectively screen potential antitumor drugs. Furthermore, these results suggest that sanguinarine may be a natural antitumor compound that targets lung CSCs, laying a foundation for further clinical study.
Similar content being viewed by others
References
Yancik R. Population aging and cancer: a cross-national concern. Cancer J. 2005;11:437–41.
Hussain SA, Sullivan R. Cancer control in Bangladesh. Jpn J Clin Oncol. 2013;43:1159–69. doi:10.1093/jjco/hyt140.
Proctor RN. Tobacco and the global lung cancer epidemic. Nat Rev Cancer. 2001;1:82–6. doi:10.1038/35094091.
Chen XM, Xie XB, Zhao Q, Wang F, Bai Y, Yin JQ, Jiang H, Xie XL, Jia Q, Huang G. Ampelopsin induces apoptosis by regulating multiple c-Myc/S-phase kinase-associated protein 2/F-box and WD repeat-containing protein 7/histone deacetylase 2 pathways in human lung adenocarcinoma cells. Mol Med Rep. 2015;11:105–12. doi:10.3892/mmr.2014.2733.
Duffy A, Le J, Sausville E, Emadi A. Autophagy modulation: a target for cancer treatment development. Cancer Chemother Pharmacol. 2015;75:439–47. doi:10.1007/s00280-014-2637-z.
Michl M, Heinemann V, Jung A, Engel J, Kirchner T, Neumann J. Expression of cancer stem cell markers in metastatic colorectal cancer correlates with liver metastasis, but not with metastasis to the central nervous system. Pathol Res Pract. 2015;211:601–9. doi:10.1016/j.prp.2015.05.006.
Noubissi FK, Harkness T, Alexander CM, Ogle BM. Apoptosis-induced cancer cell fusion: a mechanism of breast cancer metastasis. FASEB J. 2015;29:4036–45. doi:10.1096/fj.15-271098.
Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS, CW W. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 2010;70:10433–44. doi:10.1158/0008-5472.CAN-10-2638.
Chung LY, Tang SJ, YC W, Sun GH, Liu HY, Sun KH. Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with beta-catenin. Oncotarget. 2015;6:4936–52. doi:10.18632/oncotarget.3210.
Han J, Zhang F, Yu M, Zhao P, Ji W, Zhang H, Wu B, Wang Y, Niu R. RNA interference-mediated silencing of NANOG reduces cell proliferation and induces G0/G1 cell cycle arrest in breast cancer cells. Cancer Lett. 2012;321:80–8. doi:10.1016/j.canlet.2012.02.021.
Crispo M, Vilarino M, dos Santos-Neto PC, Nunez-Olivera R, Cuadro F, Barrera N, Mulet AP, Nguyen TH, Anegon I, Menchaca A. Embryo development, fetal growth and postnatal phenotype of eGFP lambs generated by lentiviral transgenesis. Transgenic Res. 2015;24:31–41. doi:10.1007/s11248-014-9816-x.
Li SJ, Yang XN, Qian HY. Antitumor effects of WNT2B silencing in GLUT1 overexpressing cisplatin resistant head and neck squamous cell carcinoma. Am J Cancer Res. 2015;5:300–8.
Alford SH, Rattan R, Buekers TE, Munkarah AR. Protective effect of bisphosphonates on endometrial cancer incidence in data from the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Cancer. 2015;121:441–7. doi:10.1002/cncr.28952.
Ohshio Y, Teramoto K, Hanaoka J, Tezuka N, Itoh Y, Asai T, Daigo Y, Ogasawara K. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine. Cancer Sci. 2015;106:134–42. doi:10.1111/cas.12584.
Li Y, Zhang T, Korkaya H, Liu S, Lee HF, Newman B, Yu Y, Clouthier SG, Schwartz SJ, Wicha MS, Sun D. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res. 2010;16:2580–90. doi:10.1158/1078-0432.CCR-09-2937.
Park H, Bergeron E, Senta H, Guillemette K, Beauvais S, Blouin R, Sirois J, Faucheux N. Sanguinarine induces apoptosis of human osteosarcoma cells through the extrinsic and intrinsic pathways. Biochem Bioph Res Co. 2010;399:446–51. doi:10.1016/j.bbrc.2010.07.114.
Jang BC, Park JG, Song DK, Baek WK, Yoo SK, Jung KH, Park GY, Lee TY, Suh SI. Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion. Toxicol in Vitro. 2009;23(2):281–7. doi:10.1016/j.tiv.2008.12.013.
Chang KC, Leung CC, Tam CM. Toward optimizing treatment for Mycobacterium avium complex lung disease. Am J Rep Crit Care. 2007;175:860. doi:10.1164/ajrccm.175.8.860.
Acknowledgments
This work was supported by grants from the National Natural Science Foundation (81473627), Shanghai Natural Science Foundation (14ZR1439000), Bureau-Level Scientific Research Projects of Shanghai Municipal Commission of Health and Family Planning (20124078, 20134016) and Hospital Emerging and Frontier Technology Joint Research Project of Shanghai (SHDC12014127).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflicts of interest
None
Electronic supplementary material
ESM 1
(DOCX 1010 kb)
Rights and permissions
About this article
Cite this article
Yang, J., Fang, Z., Wu, J. et al. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine. Tumor Biol. 37, 13871–13883 (2016). https://doi.org/10.1007/s13277-016-5152-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-016-5152-5